369 related articles for article (PubMed ID: 27160912)
1. TET2 Regulates Mast Cell Differentiation and Proliferation through Catalytic and Non-catalytic Activities.
Montagner S; Leoni C; Emming S; Della Chiara G; Balestrieri C; Barozzi I; Piccolo V; Togher S; Ko M; Rao A; Natoli G; Monticelli S
Cell Rep; 2016 May; 15(7):1566-1579. PubMed ID: 27160912
[TBL] [Abstract][Full Text] [Related]
2. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.
Putiri EL; Tiedemann RL; Thompson JJ; Liu C; Ho T; Choi JH; Robertson KD
Genome Biol; 2014 Jun; 15(6):R81. PubMed ID: 24958354
[TBL] [Abstract][Full Text] [Related]
3. Ten-Eleven Translocation-2 (Tet2) Is Involved in Myogenic Differentiation of Skeletal Myoblast Cells in Vitro.
Zhong X; Wang QQ; Li JW; Zhang YM; An XR; Hou J
Sci Rep; 2017 Mar; 7():43539. PubMed ID: 28272491
[TBL] [Abstract][Full Text] [Related]
4. Flanking sequences influence the activity of TET1 and TET2 methylcytosine dioxygenases and affect genomic 5hmC patterns.
Adam S; Bräcker J; Klingel V; Osteresch B; Radde NE; Brockmeyer J; Bashtrykov P; Jeltsch A
Commun Biol; 2022 Jan; 5(1):92. PubMed ID: 35075236
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Regulation of Corneal Epithelial Differentiation by TET2.
Sasamoto Y; Wu S; Lee CAA; Jiang JY; Ksander BR; Frank MH; Frank NY
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769164
[TBL] [Abstract][Full Text] [Related]
6. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
Poole CJ; Lodh A; Choi JH; van Riggelen J
Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
[TBL] [Abstract][Full Text] [Related]
7. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation.
Ficz G; Branco MR; Seisenberger S; Santos F; Krueger F; Hore TA; Marques CJ; Andrews S; Reik W
Nature; 2011 May; 473(7347):398-402. PubMed ID: 21460836
[TBL] [Abstract][Full Text] [Related]
8. Tet2 Regulates Osteoclast Differentiation by Interacting with Runx1 and Maintaining Genomic 5-Hydroxymethylcytosine (5hmC).
Chu Y; Zhao Z; Sant DW; Zhu G; Greenblatt SM; Liu L; Wang J; Cao Z; Tho JC; Chen S; Liu X; Zhang P; Maciejewski JP; Nimer S; Wang G; Yuan W; Yang FC; Xu M
Genomics Proteomics Bioinformatics; 2018 Jun; 16(3):172-186. PubMed ID: 29908294
[TBL] [Abstract][Full Text] [Related]
9. Specific functions of TET1 and TET2 in regulating mesenchymal cell lineage determination.
Cakouros D; Hemming S; Gronthos K; Liu R; Zannettino A; Shi S; Gronthos S
Epigenetics Chromatin; 2019 Jan; 12(1):3. PubMed ID: 30606231
[TBL] [Abstract][Full Text] [Related]
10. TET-mediated hydroxymethylcytosine at the Pparγ locus is required for initiation of adipogenic differentiation.
Yoo Y; Park JH; Weigel C; Liesenfeld DB; Weichenhan D; Plass C; Seo DG; Lindroth AM; Park YJ
Int J Obes (Lond); 2017 Apr; 41(4):652-659. PubMed ID: 28100914
[TBL] [Abstract][Full Text] [Related]
11. 5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation.
Hon GC; Song CX; Du T; Jin F; Selvaraj S; Lee AY; Yen CA; Ye Z; Mao SQ; Wang BA; Kuan S; Edsall LE; Zhao BS; Xu GL; He C; Ren B
Mol Cell; 2014 Oct; 56(2):286-297. PubMed ID: 25263596
[TBL] [Abstract][Full Text] [Related]
12. Structural insight into substrate preference for TET-mediated oxidation.
Hu L; Lu J; Cheng J; Rao Q; Li Z; Hou H; Lou Z; Zhang L; Li W; Gong W; Liu M; Sun C; Yin X; Li J; Tan X; Wang P; Wang Y; Fang D; Cui Q; Yang P; He C; Jiang H; Luo C; Xu Y
Nature; 2015 Nov; 527(7576):118-22. PubMed ID: 26524525
[TBL] [Abstract][Full Text] [Related]
13. DNA methylcytosine dioxygenase ten-eleven translocation 2 enhances lipopolysaccharide-induced cytokine expression in human dental pulp cells by regulating MyD88 hydroxymethylation.
Wang X; Feng Z; Li Q; Yi B; Xu Q
Cell Tissue Res; 2018 Aug; 373(2):477-485. PubMed ID: 29654353
[TBL] [Abstract][Full Text] [Related]
14. Ten-eleven translocation 2 modulates allergic inflammation by 5-hydroxymethylcytosine remodeling of immunologic pathways.
Meng C; Gu L; Li Y; Li R; Cao Y; Li Z; Allen EG; Zhu D; Jin P
Hum Mol Genet; 2021 Oct; 30(21):1985-1995. PubMed ID: 34165552
[TBL] [Abstract][Full Text] [Related]
15. Control of Foxp3 stability through modulation of TET activity.
Yue X; Trifari S; Äijö T; Tsagaratou A; Pastor WA; Zepeda-Martínez JA; Lio CW; Li X; Huang Y; Vijayanand P; Lähdesmäki H; Rao A
J Exp Med; 2016 Mar; 213(3):377-97. PubMed ID: 26903244
[TBL] [Abstract][Full Text] [Related]
16. TET proteins and 5-methylcytosine oxidation in hematological cancers.
Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A
Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268
[TBL] [Abstract][Full Text] [Related]
17. Tet2 and Tet3 cooperate with B-lineage transcription factors to regulate DNA modification and chromatin accessibility.
Lio CW; Zhang J; González-Avalos E; Hogan PG; Chang X; Rao A
Elife; 2016 Nov; 5():. PubMed ID: 27869616
[TBL] [Abstract][Full Text] [Related]
18. TET enzymes augment activation-induced deaminase (AID) expression via 5-hydroxymethylcytosine modifications at the
Lio CJ; Shukla V; Samaniego-Castruita D; González-Avalos E; Chakraborty A; Yue X; Schatz DG; Ay F; Rao A
Sci Immunol; 2019 Apr; 4(34):. PubMed ID: 31028100
[TBL] [Abstract][Full Text] [Related]
19. Association of high 5-hydroxymethylcytosine levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients.
Lagos C; Carvajal P; Castro I; Jara D; González S; Aguilera S; Barrera MJ; Quest AFG; Bahamondes V; Molina C; Urzúa U; Hermoso MA; Leyton C; González MJ
Clin Immunol; 2018 Nov; 196():85-96. PubMed ID: 29894742
[TBL] [Abstract][Full Text] [Related]
20. Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX.
Ko M; An J; Bandukwala HS; Chavez L; Aijö T; Pastor WA; Segal MF; Li H; Koh KP; Lähdesmäki H; Hogan PG; Aravind L; Rao A
Nature; 2013 May; 497(7447):122-6. PubMed ID: 23563267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
